Assisting Companies in the Qualification of Single-Use Materials
53:05
USP 665 and 1665 Extractables for Components in Pharmaceutical and Biopharmaceutical Manufacturing
29:33
Good Identification Practices in Non-Targeted Screening Analyses
1:32:45
Second Webinar on the architecture of the AI Act
34:26
Extractables Testing of Bioprocessing Materials
58:02
Assessing the Use and Impact of Telemedicine in the Primary Care Setting for People with Dementia
27:24
Assuring Viral Safety of the Biopharmaceutical Process
35:50
USP (665) Focus on Component Qualification – What About Component Selection?
48:23